Cargando…
Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
Chronic infections with either hepatitis B or C virus (HBV or HCV) are among the most common risk factors for developing hepatocellular carcinoma (HCC). The hepatocarcinogenic potential of these viruses is mediated through a wide range of mechanisms, including the induction of chronic inflammation a...
Autores principales: | Alqahtani, Saleh A., Colombo, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619578/ https://www.ncbi.nlm.nih.gov/pubmed/34831314 http://dx.doi.org/10.3390/cells10113091 |
Ejemplares similares
-
Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2023) -
Viral Hepatitis and Hepatocellular Carcinoma Prevention Strategy in Japan
por: Oda, Toshitsugu
Publicado: (1999) -
Viral hepatitis and hepatocellular carcinoma
por: Michielsen, Peter P, et al.
Publicado: (2005) -
Multikinase inhibitors to treat hepatocellular carcinoma failures to sorafenib—time has come for a better approach
por: Alqahtani, Saleh A., et al.
Publicado: (2020) -
Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
por: Alqahtani, Saleh A, et al.
Publicado: (2021)